Asceniv

Asceniv

Asceniv (immune globulin intravenous, human-slra) is a prescription medicine to help adults and adolescents (12 to 17 years old) with primary immunodeficiency fight and prevent infections. ASCENIV™ is the only available IVIG product made with ADMA Biologics’ proprietary method for donor screening & plasma pooling.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

MANUFACTURER:

ADMA Biologic

CLASS:
Immune globulins (blood products)
WHAT IT TREATS:

Primary Immunodeficiency Syndrome (PI), Immune Thrombocytopenic Purpura (ITP), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Bone Marrow Transplant, B-cell Chronic Lymphocytic Leukemia, Multifocal Motor Neuropathy, and Dermatomyositis.

PRESCRIBED BY:

Neurologists
Nephrologists
Hematologists
Oncologists

HOW ADMINISTERED:
Infusion
FREQUENCY:

Every 3-4 weeks

Length of infusion:
One hour to several hours depending on the dose
FOR MORE INFORMATION: